Jintong Du

479 total citations
17 papers, 385 citations indexed

About

Jintong Du is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Jintong Du has authored 17 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Jintong Du's work include Computational Drug Discovery Methods (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Protein Tyrosine Phosphatases (3 papers). Jintong Du is often cited by papers focused on Computational Drug Discovery Methods (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Protein Tyrosine Phosphatases (3 papers). Jintong Du collaborates with scholars based in China and United States. Jintong Du's co-authors include Xuben Hou, Hao Fang, Minyong Li, Lüpei Du, Jian Zhang, Xiuwen Wang, Bei Li, Zhangjian Huang, Jianbing Wu and Zhihong Li and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Jintong Du

16 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jintong Du China 9 251 100 85 75 43 17 385
Palani Kirubakaran India 12 262 1.0× 58 0.6× 80 0.9× 116 1.5× 34 0.8× 22 416
Laxman Nallan United States 11 285 1.1× 137 1.4× 57 0.7× 71 0.9× 40 0.9× 11 544
Anton Cheltsov United States 13 338 1.3× 121 1.2× 105 1.2× 60 0.8× 42 1.0× 19 640
Sharna J. Rich United Kingdom 6 230 0.9× 50 0.5× 35 0.4× 67 0.9× 21 0.5× 7 318
Sree Kanth Sivan India 14 221 0.9× 240 2.4× 106 1.2× 165 2.2× 53 1.2× 38 495
Peng Zhan China 8 240 1.0× 161 1.6× 49 0.6× 32 0.4× 83 1.9× 9 419
Caleb Foster United States 12 333 1.3× 131 1.3× 64 0.8× 52 0.7× 40 0.9× 13 528
Hui-Yi Shiao Taiwan 12 271 1.1× 304 3.0× 114 1.3× 65 0.9× 31 0.7× 13 626
Yvette Newbatt United Kingdom 12 451 1.8× 52 0.5× 54 0.6× 53 0.7× 20 0.5× 13 583

Countries citing papers authored by Jintong Du

Since Specialization
Citations

This map shows the geographic impact of Jintong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jintong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jintong Du more than expected).

Fields of papers citing papers by Jintong Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jintong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jintong Du. The network helps show where Jintong Du may publish in the future.

Co-authorship network of co-authors of Jintong Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jintong Du. A scholar is included among the top collaborators of Jintong Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jintong Du. Jintong Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Du, Jintong, et al.. (2025). Discovery of benzimidazole-based Mcl-1 inhibitors via AlphaShape-enabled virtual screening. European Journal of Medicinal Chemistry. 301. 118229–118229.
2.
Guo, Kundian, Jintong Du, Wei Zhang, et al.. (2025). A novel ionizable lipid with comprehensive improvements in transfection potency, immune profile and safety of lipid nanoparticle. Journal of Controlled Release. 386. 114126–114126. 1 indexed citations
3.
Liang, Xiao, Huajun Zhao, Jintong Du, et al.. (2023). Discovery of benzofuran-2-carboxylic acid derivatives as lymphoid tyrosine phosphatase (LYP) inhibitors for cancer immunotherapy. European Journal of Medicinal Chemistry. 258. 115599–115599. 4 indexed citations
4.
Du, Jintong, Yu Du, Yuan Gao, et al.. (2023). Deciphering the Allosteric Activation Mechanism of SIRT6 Using Molecular Dynamics Simulations. Journal of Chemical Information and Modeling. 63(18). 5896–5902. 3 indexed citations
5.
Zhao, Zhiyuan, et al.. (2022). Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Cancer. Frontiers in Pharmacology. 13. 864342–864342. 3 indexed citations
6.
Chen, Chen, Xue Li, Huajun Zhao, et al.. (2022). Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity. Journal of Medicinal Chemistry. 65(4). 3667–3683. 27 indexed citations
7.
Hou, Xuben, Jintong Du, & Hao Fang. (2021). PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer. Journal of Cancer. 12(24). 7445–7453. 7 indexed citations
8.
Du, Jintong, Wen Li, Bo Liu, et al.. (2020). An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecule activators. Bioorganic & Medicinal Chemistry. 28(16). 115607–115607. 6 indexed citations
9.
Du, Jintong, Jing Guo, Dongwei Kang, et al.. (2020). New techniques and strategies in drug discovery. Chinese Chemical Letters. 31(7). 1695–1708. 93 indexed citations
10.
Du, Jintong, et al.. (2020). Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy. Expert Opinion on Investigational Drugs. 30(1). 61–76. 11 indexed citations
11.
Du, Jintong, Lulu Liu, Bo Liu, et al.. (2020). Structure-based Virtual screening, Biological Evaluation and Biophysical Study of Novel Mcl-1 Inhibitors. Future Medicinal Chemistry. 12(14). 1293–1304. 6 indexed citations
12.
Wang, Yang, Yawei Wang, Hui Li, et al.. (2017). Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan‑induced toxicity in patients with cancer. Oncology Letters. 14(5). 5743–5752. 8 indexed citations
13.
14.
Hou, Xuben, Jintong Du, Yi Zhou, et al.. (2015). Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8. Journal of Chemical Information and Modeling. 55(4). 861–871. 37 indexed citations
15.
Du, Jintong, Yu Qiao, Lele Sun, & Xiuwen Wang. (2014). Lymphoid-Specific Tyrosine Phosphatase (Lyp): A Potential Drug Target For Treatment of Autoimmune Diseases. Current Drug Targets. 15(3). 335–346. 12 indexed citations
16.
Hou, Xuben, Jintong Du, Jian Zhang, et al.. (2012). How to Improve Docking Accuracy of AutoDock4.2: A Case Study Using Different Electrostatic Potentials. Journal of Chemical Information and Modeling. 53(1). 188–200. 111 indexed citations
17.
Hou, Xuben, Jintong Du, Hao Fang, & Minyong Li. (2011). 3D-QSAR Study on a Series of Bcl-2 Protein Inhibitors Using Comparative Molecular Field Analysis. Protein and Peptide Letters. 18(5). 440–449. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Palani Kirubakaran Breakdown of academic impact, for papers by Laxman Nallan Breakdown of academic impact, for papers by Anton Cheltsov Breakdown of academic impact, for papers by Sharna J. Rich Breakdown of academic impact, for papers by Sree Kanth Sivan Breakdown of academic impact, for papers by Peng Zhan Breakdown of academic impact, for papers by Caleb Foster Breakdown of academic impact, for papers by Hui-Yi Shiao Breakdown of academic impact, for papers by Yvette Newbatt
Rankless by CCL
2026